Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study.
behavior and behavior mechanisms
exercise
mobile phone
type 1 diabetes mellitus
Journal
JMIR diabetes
ISSN: 2371-4379
Titre abrégé: JMIR Diabetes
Pays: Canada
ID NLM: 101719410
Informations de publication
Date de publication:
08 Jul 2021
08 Jul 2021
Historique:
received:
01
03
2021
accepted:
08
05
2021
revised:
12
04
2021
pubmed:
29
5
2021
medline:
29
5
2021
entrez:
28
5
2021
Statut:
epublish
Résumé
Our clinical trial of a mobile exercise intervention for adults 18 to 65 years old with type 1 diabetes (T1D) occurred during COVID-19 social distancing restrictions, prompting us to test web-based recruitment methods previously underexplored for this demographic. Our objectives for this study were to (1) evaluate the effectiveness and cost of using social media news feed advertisements, a clinic-based approach method, and web-based snowball sampling to reach inadequately active adults with T1D and (2) compare characteristics of enrollees against normative data. Participants were recruited between November 2019 and August 2020. In method #1, Facebook and Instagram news feed advertisements ran for five 1-to-8-day windows targeting adults (18 to 64 years old) in the greater New Haven and Hartford, Connecticut, areas with one or more diabetes-related profile interest. If interested, participants completed a webform so that the research team could contact them for eligibility screening. In method #2, patients 18 to 24 years old with T1D were approached in person at clinical visits in November and December 2019. Those who were interested immediately completed eligibility screening. Older patients could not be approached due to clinic restrictions. In method #3, snowball sampling was conducted by physically active individuals with T1D contacting their peers on Facebook and via email for 48 days, with details to contact the research staff to express interest and complete eligibility screening. Other methods referred participants to the study similarly to snowball sampling. In method #1, advertisements were displayed to 11,738 unique viewers and attracted 274 clickers (2.33%); 20 participants from this group (7.3%) volunteered, of whom 8 (40%) were eligible. Costs averaged US $1.20 per click and US $95.88 per eligible volunteer. Men had lower click rates than women (1.71% vs 3.17%; P<.001), but their responsiveness and eligibility rates did not differ. In method #2, we approached 40 patients; 32 of these patients (80%) inquired about the study, of whom 20 (63%) volunteered, and 2 of these volunteers (10%) were eligible. Costs including personnel for in-person approaches averaged US $21.01 per inquirer and US $479.79 per eligible volunteer. In method #3, snowball sampling generated 13 inquirers; 12 of these inquirers (92%) volunteered, of whom 8 (67%) were eligible. Incremental costs to attract inquirers were negligible, and total costs averaged US $20.59 per eligible volunteer. Other methods yielded 7 inquirers; 5 of these inquirers (71%) volunteered, of whom 2 (40%) were eligible. Incremental costs to attract inquirers were negligible, and total costs averaged US $34.94 per eligible volunteer. Demographic overrepresentations emerged in the overall cohort (ie, optimal glycemic control, obesity, and low exercise), among those recruited by news feed advertisements (ie, obesity and older age), and among those recruited by snowball sampling (ie, optimal glycemic control and low exercise). Web-based advertising and recruitment strategies are a promising means to attract adults with T1D to clinical trials and exercise interventions, with costs comparing favorably to prior trials despite targeting an uncommon condition (ie, T1D) and commitment to an intervention. These strategies should be tailored in future studies to increase access to higher-risk participants. ClinicalTrials.gov NCT04204733; https://clinicaltrials.gov/ct2/show/NCT04204733.
Sections du résumé
BACKGROUND
BACKGROUND
Our clinical trial of a mobile exercise intervention for adults 18 to 65 years old with type 1 diabetes (T1D) occurred during COVID-19 social distancing restrictions, prompting us to test web-based recruitment methods previously underexplored for this demographic.
OBJECTIVE
OBJECTIVE
Our objectives for this study were to (1) evaluate the effectiveness and cost of using social media news feed advertisements, a clinic-based approach method, and web-based snowball sampling to reach inadequately active adults with T1D and (2) compare characteristics of enrollees against normative data.
METHODS
METHODS
Participants were recruited between November 2019 and August 2020. In method #1, Facebook and Instagram news feed advertisements ran for five 1-to-8-day windows targeting adults (18 to 64 years old) in the greater New Haven and Hartford, Connecticut, areas with one or more diabetes-related profile interest. If interested, participants completed a webform so that the research team could contact them for eligibility screening. In method #2, patients 18 to 24 years old with T1D were approached in person at clinical visits in November and December 2019. Those who were interested immediately completed eligibility screening. Older patients could not be approached due to clinic restrictions. In method #3, snowball sampling was conducted by physically active individuals with T1D contacting their peers on Facebook and via email for 48 days, with details to contact the research staff to express interest and complete eligibility screening. Other methods referred participants to the study similarly to snowball sampling.
RESULTS
RESULTS
In method #1, advertisements were displayed to 11,738 unique viewers and attracted 274 clickers (2.33%); 20 participants from this group (7.3%) volunteered, of whom 8 (40%) were eligible. Costs averaged US $1.20 per click and US $95.88 per eligible volunteer. Men had lower click rates than women (1.71% vs 3.17%; P<.001), but their responsiveness and eligibility rates did not differ. In method #2, we approached 40 patients; 32 of these patients (80%) inquired about the study, of whom 20 (63%) volunteered, and 2 of these volunteers (10%) were eligible. Costs including personnel for in-person approaches averaged US $21.01 per inquirer and US $479.79 per eligible volunteer. In method #3, snowball sampling generated 13 inquirers; 12 of these inquirers (92%) volunteered, of whom 8 (67%) were eligible. Incremental costs to attract inquirers were negligible, and total costs averaged US $20.59 per eligible volunteer. Other methods yielded 7 inquirers; 5 of these inquirers (71%) volunteered, of whom 2 (40%) were eligible. Incremental costs to attract inquirers were negligible, and total costs averaged US $34.94 per eligible volunteer. Demographic overrepresentations emerged in the overall cohort (ie, optimal glycemic control, obesity, and low exercise), among those recruited by news feed advertisements (ie, obesity and older age), and among those recruited by snowball sampling (ie, optimal glycemic control and low exercise).
CONCLUSIONS
CONCLUSIONS
Web-based advertising and recruitment strategies are a promising means to attract adults with T1D to clinical trials and exercise interventions, with costs comparing favorably to prior trials despite targeting an uncommon condition (ie, T1D) and commitment to an intervention. These strategies should be tailored in future studies to increase access to higher-risk participants.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov NCT04204733; https://clinicaltrials.gov/ct2/show/NCT04204733.
Identifiants
pubmed: 34047700
pii: v6i3e28309
doi: 10.2196/28309
pmc: PMC8299346
doi:
Banques de données
ClinicalTrials.gov
['NCT04204733']
Types de publication
Journal Article
Langues
eng
Pagination
e28309Subventions
Organisme : CSRD VA
ID : I01 CX001825
Pays : United States
Organisme : NINR NIH HHS
ID : K99 NR018886
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK111022
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
©Garrett I Ash, Stephanie Griggs, Laura M Nally, Matthew Stults-Kolehmainen, Sangchoon Jeon, Cynthia Brandt, Barbara I Gulanski, Elias K Spanakis, Julien S Baker, Robin Whittemore, Stuart A Weinzimer, Lisa M Fucito. Originally published in JMIR Diabetes (https://diabetes.jmir.org), 08.07.2021.
Références
J Med Internet Res. 2017 Aug 28;19(8):e290
pubmed: 28851679
Ann Intern Med. 1997 Oct 15;127(8 Pt 2):752-6
pubmed: 9382393
JMIR Cancer. 2019 May 28;5(1):e7850
pubmed: 31140436
Digit Health. 2019 Aug 06;5:2055207619867223
pubmed: 31431827
Diabetes Care. 2021 Jan;44(Suppl 1):S53-S72
pubmed: 33298416
J Med Internet Res. 2020 Aug 11;22(8):e17449
pubmed: 32780027
BMJ Open. 2018 Nov 28;8(11):e022234
pubmed: 30498037
Diabetes Educ. 2016 Feb;42(1):108-15
pubmed: 26655391
J Diabetes Sci Technol. 2018 May;12(3):712-718
pubmed: 29310448
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
J Diabetes Sci Technol. 2019 May;13(3):445-456
pubmed: 31010315
J Med Internet Res. 2020 Sep 29;22(9):e21204
pubmed: 32990632
J Med Internet Res. 2018 Apr 20;20(4):e151
pubmed: 29678801
Diabet Med. 2012 Nov;29(11):e402-8
pubmed: 22817453
JAMA Oncol. 2019 Oct 1;5(10):e191870
pubmed: 31415071
JMIR Diabetes. 2019 Apr 02;4(2):e13634
pubmed: 30938693
JMIR Mhealth Uhealth. 2021 Jan 18;9(1):e16282
pubmed: 33459598
Psychol Sport Exerc. 2012 Nov;13(6):779-788
pubmed: 22844226
Diabetes Spectr. 2018 Aug;31(3):267-271
pubmed: 30140143
Diabetes Technol Ther. 2021 May;23(5):376-383
pubmed: 33259257
Res Nurs Health. 2020 Aug;43(4):317-328
pubmed: 32639059
J Diabetes Sci Technol. 2020 Nov;14(6):1022-1027
pubmed: 31646890
Am Psychol. 2020 Feb-Mar;75(2):235-251
pubmed: 32052997
Clin Trials. 2020 Dec;17(6):664-674
pubmed: 32627589
Diabetes Care. 2008 Nov;31(11):2108-9
pubmed: 18689694
Contemp Clin Trials. 2021 Jan;100:106217
pubmed: 33197609
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Appl Physiol Nutr Metab. 2011 Jul;36 Suppl 1:S266-98
pubmed: 21800945
Diabetes Spectr. 2015 May;28(2):99-105
pubmed: 25987808
Front Neurosci. 2017 Nov 02;11:612
pubmed: 29163016
Endocr Rev. 2018 Apr 1;39(2):79-132
pubmed: 29518206
Am J Health Promot. 2018 May;32(4):1070-1077
pubmed: 28812371
Diabetes Obes Metab. 2020 Sep;22(9):1577-1585
pubmed: 32329127
J Med Internet Res. 2016 May 18;18(5):e107
pubmed: 27194456
BMJ Open. 2018 Jan 24;8(1):e017813
pubmed: 29371269
J Med Internet Res. 2020 Oct 26;22(10):e22810
pubmed: 33104015
Pediatr Diabetes. 2019 Jun;20(4):450-459
pubmed: 30834621